XBIO REPORT

Tag: Oncology Pipeline

January 22, 2026

Plus Therapeutics Delivers Key Updates on REYOBIQ and CNSide Commercial Strategy

NASDAQ: $PSTV In a significant communication to investors and the medical community, Plus Therapeutics, Inc. has recently issued a comprehensive business update focusing on two critical aspects of its pipeline and commercial strategy: the clinical program for REYOBIQ (also known as the LOTUS trial) and the planned U.S. commercialization pathway for CNSide. Advancements in the…

Clinical Trial

$PSTV, CNSide, Leptomeningeal Metastases, Oncology Pipeline, Plus Therapeutics, REYOBIQ
January 15, 2026

Ascentage Pharma Shares Vision for Global Expansion at J.P. Morgan Conference

NASDAQ: $AAPG The recent 44th Annual J.P. Morgan Healthcare Conference served as a pivotal stage for Ascentage Pharma to articulate its comprehensive strategy for worldwide growth and innovation. The company, a dynamic force in the biopharmaceutical sector, used its presentation slot to detail how it plans to propel its pipeline from clinical promise to global…

Conferences

$AAPG, Ascentage Pharma, Biotech Innovation, Global Strategy, J.P. Morgan Conference, Oncology Pipeline